These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Mechanisms that inhibit the formation and manifestation of the myocardial depressant factor in shock states]. Lefer AM Khirurgiia (Sofiia); 1980; 33(5):377-85. PubMed ID: 7003214 [No Abstract] [Full Text] [Related]
25. Role of a myocardial depressant factor in shock states. Lefer AM Mod Concepts Cardiovasc Dis; 1973 Dec; 42(12):59-64. PubMed ID: 4205659 [No Abstract] [Full Text] [Related]
26. Myocardial blood flow and methabolism during and after hemorrhagic shock in the dog. Heimbach DM; Fisher WD; Hutton I; McArdle CS; Ledingham IM Surg Gynecol Obstet; 1973 Aug; 137(2):243-52. PubMed ID: 4723347 [No Abstract] [Full Text] [Related]
27. [Effect of administration of a large dose of corticosteroids in hemorrhagic shock]. Okada K; Kosugi I; Yamaguchi S; Innan H; Kawashima Y Masui; 1974 Nov; 23(12):1170-7. PubMed ID: 4477607 [No Abstract] [Full Text] [Related]
28. Myocardial depression in septic shock: physiologic and metabolic effects of a plasma factor on an isolated heart. Maksad AK; Cha CJ; Stuart RC; Brosco FA; Clowes GH Surg Forum; 1978; 29():23-5. PubMed ID: 401143 [No Abstract] [Full Text] [Related]
29. Cardiac factors in shock. Glass BA J La State Med Soc; 1967 Jan; 119(1):10-2. PubMed ID: 6039406 [No Abstract] [Full Text] [Related]
30. Evidence for a role of platelet activating factor in hypovolemic shock in the rat. Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759 [TBL] [Abstract][Full Text] [Related]
31. Myocardial dysfunction in endotoxin- and E. coli-induced shock: pathophysiological mechanisms. Archer LT Circ Shock; 1985; 15(4):261-80. PubMed ID: 3888434 [TBL] [Abstract][Full Text] [Related]
32. Depression of myocardial contractility is not a causative factor for circulatory deterioration in two experimental models of shock in anesthetized dogs. Jacinto SM; Jandhyala BS Ann N Y Acad Sci; 1994 Jun; 723():345-8. PubMed ID: 8030881 [No Abstract] [Full Text] [Related]
33. Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Lefer AM Fed Proc; 1970; 29(6):1836-47. PubMed ID: 5482718 [No Abstract] [Full Text] [Related]
34. [Pancreas--shock organ and shock mediator]. Müller MK; Singer MV Dtsch Med Wochenschr; 1992 Jan; 117(1):27-32. PubMed ID: 1730196 [No Abstract] [Full Text] [Related]
35. A study of the myocardial depressant factor and its relative influence in drug/alcohol mortality. Manning TJ; Williams LE; Lynch VD; Bidanset JH; Drake W; Lukash L J Forensic Sci; 1980 Jul; 25(3):550-63. PubMed ID: 7400768 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of ethylketocyclazocine in hemorrhagic shock. Curtis MT; Lefer AM Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972 [TBL] [Abstract][Full Text] [Related]
37. Experimental studies of cardiac function during irreversible hemorrhagic shock. Brough RD Tex Med; 1971 Sep; 67(9):50-7. PubMed ID: 5115783 [No Abstract] [Full Text] [Related]
39. The role of the heart in shock: exsanguination studies. Albert HM; Glass BA; Carter RL Am Surg; 1968 Jan; 34(1):48-52. PubMed ID: 5635301 [No Abstract] [Full Text] [Related]